· Weekly signal · AXSM
Axsome Therapeutics Inc (AXSM) finishes week 9.8% higher in active trend
The CNS-therapy developer’s twelve-week return is now 62.6%, putting the move in a broader biotech rebound rather than a single-week move.
Axsome Therapeutics Inc (AXSM) closed the latest week at $255.17, extending its four-week advance to 12.1% as of June 12. The Healthcare stock remains a large-cap biotechnology mover with a market value of about $12.0 billion.
In the weekly price path over 52 weeks, the trend signal is active and volume was near normal at 3.44 million shares, or 0.99x the 13-week average. Market Dynamics at 1.15 adds confirmation, but Relative Strength at 41.2 leaves the evidence mixed rather than uniformly strong.